Literature DB >> 20946352

Human faecal microbiota display variable patterns of glycerol metabolism.

Rosemarie De Weirdt1, Sam Possemiers, Griet Vermeulen, Tanja C W Moerdijk-Poortvliet, Henricus T S Boschker, Willy Verstraete, Tom Van de Wiele.   

Abstract

Significant amounts of glycerol reach the colon microbiota daily through the diet and/or by in situ microbial production or release from desquamated epithelial cells. Some gut microorganisms may anaerobically reduce glycerol to 1,3-propanediol (1,3-PDO), with 3-hydroxypropanal as an intermediate. Accumulation of the latter intermediate may result in the formation of reuterin, which is known for its biological activity (e.g. antimicrobial properties). To date, glycerol metabolism in mixed cultures from the human colon has received little attention. Using in vitro batch incubations of faeces from 10 human individuals, we demonstrated that glycerol addition (140 mM) significantly affects the metabolism and composition of the microbial community. About a third of the samples exhibited rapid glycerol conversion, yielding proportionally higher levels of acetate and 1,3-PDO. In contrast, a slower glycerol metabolism resulted in higher levels of propionate. Furthermore, rapid glycerol metabolism correlated with significant shifts in the Lactobacillus-Enterococcus community, which were not observed in slower glycerol-metabolizing samples. As the conversion of glycerol to 1,3-PDO is a highly reducing process, we infer that the glycerol metabolism may act as an effective hydrogen sink. Given the importance of hydrogen-consuming processes in the gut, this work suggests that glycerol may have potential as a tool for modulating fermentation kinetics and profiles in the gastrointestinal tract.
© 2010 Federation of European Microbiological Societies. Published by Blackwell Publishing Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20946352     DOI: 10.1111/j.1574-6941.2010.00974.x

Source DB:  PubMed          Journal:  FEMS Microbiol Ecol        ISSN: 0168-6496            Impact factor:   4.194


  43 in total

1.  Comparative methods for fecal sample storage to preserve gut microbial structure and function in an in vitro model of the human colon.

Authors:  Charlotte Deschamps; Elora Fournier; Ophélie Uriot; Frédérique Lajoie; Cécile Verdier; Sophie Comtet-Marre; Muriel Thomas; Nathalie Kapel; Claire Cherbuy; Monique Alric; Mathieu Almeida; Lucie Etienne-Mesmin; Stéphanie Blanquet-Diot
Journal:  Appl Microbiol Biotechnol       Date:  2020-10-21       Impact factor: 4.813

2.  Butyrate-producing Clostridium cluster XIVa species specifically colonize mucins in an in vitro gut model.

Authors:  Pieter Van den Abbeele; Clara Belzer; Margot Goossens; Michiel Kleerebezem; Willem M De Vos; Olivier Thas; Rosemarie De Weirdt; Frederiek-Maarten Kerckhof; Tom Van de Wiele
Journal:  ISME J       Date:  2012-12-13       Impact factor: 10.302

3.  An Integrated Approach to Recognize Potential Protective Effects of Culinary Herbs Against Chronic Diseases.

Authors:  Suganya Chandrababu; Dhundy Bastola
Journal:  J Healthc Inform Res       Date:  2018-11-19

4.  Adaptation of commensal proliferating Escherichia coli to the intestinal tract of young children with cystic fibrosis.

Authors:  Susana Matamouros; Hillary S Hayden; Kyle R Hager; Mitchell J Brittnacher; Kristina Lachance; Eli J Weiss; Christopher E Pope; Anne-Flore Imhaus; Colin P McNally; Elhanan Borenstein; Lucas R Hoffman; Samuel I Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-29       Impact factor: 11.205

5.  Next-Generation Probiotics Targeting Clostridium difficile through Precursor-Directed Antimicrobial Biosynthesis.

Authors:  Jennifer K Spinler; Jennifer Auchtung; Aaron Brown; Prapaporn Boonma; Numan Oezguen; Caná L Ross; Ruth Ann Luna; Jessica Runge; James Versalovic; Alex Peniche; Sara M Dann; Robert A Britton; Anthony Haag; Tor C Savidge
Journal:  Infect Immun       Date:  2017-09-20       Impact factor: 3.441

6.  Effect of a novel animal milk oligosaccharide biosimilar on the gut microbial communities and metabolites of in vitro incubations using feline and canine fecal inocula.

Authors:  Patrícia M Oba; Sara Vidal; Romain Wyss; Yong Miao; Yemi Adesokan; Kelly S Swanson
Journal:  J Anim Sci       Date:  2020-09-01       Impact factor: 3.159

7.  Influenza Virus Infection Impairs the Gut's Barrier Properties and Favors Secondary Enteric Bacterial Infection through Reduced Production of Short-Chain Fatty Acids.

Authors:  Valentin Sencio; Alexandre Gallerand; Marina Gomes Machado; Lucie Deruyter; Séverine Heumel; Daphnée Soulard; Johanna Barthelemy; Céline Cuinat; Angelica T Vieira; Adeline Barthelemy; Luciana P Tavares; Rodolphe Guinamard; Stoyan Ivanov; Corinne Grangette; Mauro M Teixeira; Benoit Foligné; Isabelle Wolowczuk; Ronan Le Goffic; Muriel Thomas; François Trottein
Journal:  Infect Immun       Date:  2021-08-16       Impact factor: 3.441

8.  Comparative Effect of 22 Dietary Sources of Fiber on Gut Microbiota of Healthy Humans in vitro.

Authors:  Marta Calatayud; Pieter Van den Abbeele; Jonas Ghyselinck; Massimo Marzorati; Eric Rohs; Anne Birkett
Journal:  Front Nutr       Date:  2021-07-02

9.  Probiotic and Functional Properties of Limosilactobacillus reuteri INIA P572.

Authors:  Patricia Diez-Echave; Izaskun Martín-Cabrejas; José Garrido-Mesa; Susana Langa; Teresa Vezza; José M Landete; Laura Hidalgo-García; Francesca Algieri; Melinda J Mayer; Arjan Narbad; Ana García-Lafuente; Margarita Medina; Alba Rodríguez-Nogales; María Elena Rodríguez-Cabezas; Julio Gálvez; Juan L Arqués
Journal:  Nutrients       Date:  2021-05-29       Impact factor: 6.706

10.  Microbiotas from UC patients display altered metabolism and reduced ability of LAB to colonize mucus.

Authors:  Louise Kristine Vigsnaes; Pieter van den Abbeele; Karolina Sulek; Henrik Lauritz Frandsen; Casper Steenholdt; Jørn Brynskov; Joan Vermeiren; Tom van de Wiele; Tine Rask Licht
Journal:  Sci Rep       Date:  2013-01-23       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.